9JUN

Ebola passes 1,000 cases in DRC

3 min read

09:58UTC

WHO bulletin DON605 logged 1,040 Bundibugyo Ebola cases and 241 deaths on 29 May, up from 831 and 186 eight days earlier. Laboratory-confirmed cases jumped 58%, from 85 to 134.

← Back to Ebola outbreak gets an R0, and a fork Jump to analysis ↓

ScienceDeveloping

Key takeaway

Bundibugyo Ebola has passed 1,040 cases and 241 deaths, with confirmed cases up 58% in eight days.

The World Health Organization published Disease Outbreak News bulletin DON605 on Friday 29 May, recording 1,040 total Bundibugyo Ebola cases and 241 deaths in the Democratic Republic of Congo and Uganda ¹. The WHO is the United Nations health agency coordinating the international response; Disease Outbreak News is its formal channel for reporting verified outbreak data. Eight days earlier, DON603 had logged 831 cases and 186 deaths , so the burden rose roughly 25% in cases and 30% in deaths in a single week.

The sharpest movement was in laboratory-confirmed cases, which climbed from 85 to 134, a 58% rise, with confirmed deaths up from 10 to 18. Confirmed numbers grew faster than total numbers partly because testing caught up after the 17 May emergency declaration , so some of the jump reflects faster case-finding rather than faster transmission. The outbreak is centred on Ituri Province in north-eastern DRC, the zone bordering Uganda.

Bundibugyo ebolavirus is one of six Ebola species and last caused a large outbreak in Uganda in 2007. The human stakes sit in the total burden, not the headline percentage: 241 people have now died, and 906 of the 1,040 cases are still awaiting laboratory confirmation, a backlog that keeps the true picture ahead of the record.

Deep Analysis

In plain English

Ebola outbreaks grow in two separate counts: total suspected cases (anyone with fever and Ebola symptoms) and laboratory-confirmed cases (people where a blood test came back positive). The WHO bulletin of 29 May shows 1,040 total suspected cases but only 134 confirmed ones. That gap matters because the confirmed figure is what gets counted as the official outbreak total for international purposes. The jump of 58% in confirmed cases between 21 and 29 May happened partly because more lab tests are now being processed, and partly because the virus was already spreading in communities before the outbreak was formally identified in early May. Think of it like turning on a light in a dark room: the cases were always there; the light just revealed them. Ituri Province, where almost all cases are concentrated, is a remote part of north-eastern Democratic Republic of Congo. The roads are poor and armed groups are active in the area, making it hard for health workers to reach sick people or trace their contacts.

Deep Analysis

Root Causes

The nine-day lag between the 5 May WHO signal and the 14 May INRB species confirmation reflects a structural bottleneck in the DRC reference laboratory system: INRB in Kinshasa is the sole body certified to confirm Ebola species in DRC, and sample transport from Ituri Province requires cold-chain logistics across 2,000 km of poorly maintained roads. The Ituri provincial health system lacks a BSL-3 laboratory capable of running filovirus PCR assays independently.

A second structural cause is low contact-tracing coverage: DON603 (21 May) recorded only 21% of named contacts being followed up, a direct consequence of insecurity from ADF and CODECO armed-group activity in the Djugu territory at the outbreak's core.

The Tom Frieden-originated 7-1-7 benchmark (seven days to detect, seven days to notify, seven days to respond) requires a functional community health worker system and safe access to index patients' contacts. Both conditions were absent for at least six weeks of pre-detection transmission.

What could happen next?

Risk
A 25% total-case rise in eight days, combined with only 21% contact-tracing coverage, indicates the transmission chain is ahead of the surveillance and isolation effort.
Consequence
At the current seven-day doubling trajectory for confirmed cases, the outbreak could exceed 2,000 total cases within three to four weeks without a step-change in containment.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: The 2018-2020 eastern DRC Kivu Ebola outbreak (Zaire ebolavirus, 3,481 cases over 22 months) followed a structurally identical early trajectory: an initial WHO signal received weeks after community transmission had already seeded multiple health zones, followed by a case doubling in the first three reporting cycles as contact-tracing and laboratory capacity caught up.

The Kivu outbreak had the rVSV-ZEBOV (Ervebo) vaccine and three licensed therapeutics (Inmazeb, Ebanga, ZMapp trials) available within weeks. The 2026 Bundibugyo PHEIC carries the same surveillance-lag dynamic but without any licensed countermeasure.

Counter-parallel: The 2000 Gulu Sudan ebolavirus outbreak in Uganda showed that a community-transmission head start did not prevent containment: 425 cases were eventually controlled in 173 days using barrier nursing, contact tracing, and safe-burial protocols alone, with no vaccine. The limiting factor in Gulu was community trust and physical access to patients, not the absence of medical countermeasures.

Consensus view: Anne Cori and Neil Ferguson at Imperial College London's MRC Centre for Global Infectious Disease Analysis assessed on 17 May that the outbreak had been circulating undetected for at least four to six weeks before WHO received a signal on 5 May.

The 25% total-case rise and 58% laboratory-confirmed-case rise between 21 and 29 May are consistent with a period in which confirmed-case counts lag transmission by one to two incubation cycles (two to 21 days), meaning the case acceleration was likely already embedded in the transmission chain before DON605's data were collected.

Counter-view: Africa CDC Director-General Jean Kaseya has argued that the confirmed-case surge partly reflects improved laboratory throughput and expanded case-finding after the 17 May PHEIC mobilised resources, not purely ongoing transmission acceleration. Under this framing, more confirmed cases can be a sign of a response gaining traction, not solely of an outbreak outrunning containment.

Key tension: Whether the 58% confirmed-case rise in eight days reflects genuine transmission growth, laboratory catch-up, or both, and which interpretation should set the resource-mobilisation pace.

Sources:World Health Organization

Mentions:World Health Organization →Ituri Province →DON 600 →Inmazeb →Uganda →Africa CDC →PHEIC →Neil Ferguson →Anne Cori →Ebanga →Imperial College London →Ervebo →Jean Kaseya →Zaire ebolavirus →United Nations →CDC →DR Congo →Bundibugyo ebolavirus →

First Reported In

Update #5 · Ebola money arrives, the cure does not

World Health Organization· 2 Jun 2026

Read original →

Causes and effects

Caused by

WHO declares Ebola PHEIC, no committee

The 17 May PHEIC declaration triggered accelerated case-finding which partly drove the 58% confirmed-case rise recorded in DON605.

Occurred 17 May 2026

Read story →

Bundibugyo Ebola: 831 cases, 186 dead

DON603's 831/186 baseline is the starting point from which DON605's 1,040/241 total is measured.

Occurred 21 May 2026

Read story →

This Event

Ebola passes 1,000 cases in DRC

Total burden has crossed 1,000 cases and 241 deaths, and the confirmed-case curve is still climbing eight days on.

Led to

WHO cuts the count, cases keep climbing

DON606's confirmed-only count of 534 follows directly from the 1,040 total-cases figure in DON605 which included suspected cases later cleared from the backlog

Occurred 8 Jun 2026

Read story →

Ebola model puts the fork at 20% isolation

CDC MMWR modelling was calculated against the corrected confirmed-only baseline that superseded the DON605 1,040-case count

Occurred 5 Jun 2026

Read story →

Different Perspectives

World Health Organization

WHO's DON606 recalibration to confirmed-only reporting gives the clean baseline the CDC model rests on, but the apparent fall from 1,040 to 534 carries misinterpretation risk WHO communications have not pre-empted. The PABS deadlock ahead of IGWG7 and continuing MBP134/remdesivir assessment without authorisation make WHO the body most able to accelerate the two decisions that could change the outbreak's trajectory.

European Union (ECDC)

ECDC's Week 23 CDTR tracked four simultaneous non-Ebola signals: the Dermatophilus congolensis novel-transmission cluster across France, Germany and Spain; a 4.2-fold malaria surge in Mayotte; the Salmonella ST2045 multi-country cluster; and two new Saudi MERS cases. The continental early-warning layer is carrying a full multi-pathogen picture while Bundibugyo dominates headlines.

Uganda

Uganda's 19 confirmed cases are concentrated in Kampala and Wakiso, an urban cluster that applied the 2022 Sudan-ebolavirus playbook; the Bwera border laboratory shortens cross-border confirmation to same-day. Uganda's regulatory authority must co-sign before MBP134 or remdesivir can dose any patient.

Democratic Republic of the Congo

Kinshasa shares Bundibugyo sequence data in real time with no treaty-guaranteed access to the vaccines that data informs, and its health minister called the US entry ban discriminatory while negotiating an early lift. DRC accounts for 515 of 534 confirmed cases and faces IS-controlled access blockades in Mambasa that health authorities cannot resolve.

United States (HHS/CDC)

HHS expanded the Ebola entry ban to green-card holders on 5 June, widening a restriction expiring around 17 June against WHO advice. The CDC simultaneously published the R0=2.51 modelling, the sharpest analytical contribution to the response, from a federal bench that holds the NIH and acting CDC director roles in one person.

Imperial College London / Cori and Ferguson

Anne Cori and Neil Ferguson place the case-fatality ratio at 30 to 40 per cent and read the 6.8-to-1 suspected-to-confirmed ratio as evidence that the laboratory figure understates true lethality. Many people die before a swab reaches them.